Extracellular Vesicle-Related Non-Coding RNAs in Hepatocellular Carcinoma: An Overview
Augello, G.; Cusimano, A.; Cervello, M.; Cusimano, A.
CANCERS
IF WOS: NA SJR: 1.462 Best Quartile: Q1
Posizione: 1/4

Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma
Giannitrapani, L.; Di Gaudio, F.; Cervello, M.; Scionti, F.; Ciliberto, D.; Staropoli, N.; Agapito, G.; Cannataro, M.; Tassone, P.; Tagliaferri, P.; et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
IF WOS: NA SJR: 1.273 Best Quartile: Q1
Posizione: 20/21

Photoaging of polystyrene-based microplastics amplifies inflammatory response in macrophages
Aloi, Noemi; Calarco, Anna; Curcuruto, Giusy; Di Natale, Marilena; Augello, Giuseppa; Carroccio, Sabrina Carola; Cerruti, Pierfrancesco; Cervello, Melchiorre; Cuttitta, Angela; Colombo, Paolo; et al.
CHEMOSPHERE
IF WOS: 8.100 SJR: 1.896 Best Quartile: Q1
Posizione: 5/11

The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH
Cervello, Melchiorre; Augello, Giuseppa; Cocco, Lucio; Ratti, Stefano; Follo, Matilde Y.; Martelli, Alberto M.; Cusimano, Antonella; Montalto, Giuseppe; Mccubrey, James A.
ADVANCES IN BIOLOGICAL REGULATION
IF WOS: NA SJR: 0.969 Best Quartile: Q2
Posizione: 2/9

New Insights into the Behavior of NHC-Gold Complexes in Cancer Cells
Augello, Giuseppa; Azzolina, Antonina; Rossi, Filomena; Prencipe, Filippo; Mangiatordi, GIUSEPPE FELICE; Saviano, Michele; Ronga, Luisa; Cervello, Melchiorre; Tesauro, Diego
PHARMACEUTICS
IF WOS: NA SJR: 0.892 Best Quartile: Q1
Posizione: 1/9

Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression
Mccubrey, Ja; Yang, Lv; Abrams, Sl; Steelman, Ls; Follo, My; Cocco, L; Ratti, S; Martelli, Am; Augello, G; Cervello, M
CELLS
IF WOS: NA SJR: 1.537 Best Quartile: Q1
Posizione: 9/10

miR-126-3p and miR-21-5p as Hallmarks of Bio-Positive Ageing; Correlation Analysis and Machine Learning Prediction in Young to Ultra-Centenarian Sicilian Population
Accardi, G; Bono, F; Cammarata, G; Aiello, A; Herrero, Mt; Alessandro, R; Augello, G; Carru, C; Colomba, P; Costa, Ma; et al.
CELLS
IF WOS: NA SJR: 1.537 Best Quartile: Q1
Posizione: 7/19

Outcome predictors in SARS-CoV-2 disease (COVID-19): The prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population
Giannitrapani, L; Augello, G; Mirarchi, L; Amodeo, S; Veronese, N; Sasso, Bl; Giglio, Rv; Licata, A; Barbagallo, M; Ciaccio, M; et al.
JOURNAL OF INFECTION
IF WOS: 27.300 SJR: 3.904 Best Quartile: Q1
Posizione: 2/12

The clinical impact of an extra virgin olive oil enriched mediterranean diet on metabolic syndrome: Lights and shadows of a nutraceutical approach
Seidita, A; Soresi, M; Giannitrapani, L; Di Stefano, V; Citarrella, R; Mirarchi, L; Cusimano, A; Augello, G; Carroccio, A; Iovanna, Jl; et al.
FRONTIERS IN NUTRITION
IF WOS: 4.600 SJR: 0.875 Best Quartile: Q1
Posizione: 8/11

GSK-3 in liver diseases: Friend or foe?
Emma MR; Augello G; Cusimano A; Azzolina A; Montalto G; McCubrey JA; Cervello M;
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
IF WOS: 4.739 SJR: 1.715 Best Quartile: Q2
Posizione: 2/7

Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis
R Emma, Maria; Giannitrapani, Lydia; Cabibi, Daniela; Porcasi, Rossana; Pantuso, Gianni; Augello, Giuseppa; V Giglio, Rosaria; Lo Re, Noemi; R Capitano, Adele; Montalto, Giuseppe; et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
IF WOS: 4.698 SJR: 1.769 Best Quartile: Q1
Posizione: 6/12

The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods
Soresi M; Cabibi D; Giglio RV; Martorana S; Guercio G; Porcasi R; Terranova A; Lazzaro LA; Emma MR; Augello G; et al.
BIOMED RESEARCH INTERNATIONAL
IF WOS: 3.411 SJR: 0.772 Best Quartile: Q2
Posizione: 10/14

The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment
Augello G; Emma MR; Cusimano A; Azzolina A; Montalto G; McCubrey JA; Cervello M;
CELLS
IF WOS: NA SJR: 1.22 Best Quartile: Q1
Posizione: 1/7

RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma
Akula, Sm; Abrams, Sl; Steelman, Ls; Emma, Mr; Augello, G; Cusimano, A; Azzolina, A; Montalto, G; Cervello, M; Mccubrey, Ja
EXPERT OPINION ON THERAPEUTIC TARGETS
IF WOS: 5.473 SJR: 1.699 Best Quartile: Q1
Posizione: 5/10

Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma
Augello, G; Emma, Mr; Cusimano, A; Azzolina, A; Mongiovi, S; Puleio, R; Cassata, G; Gulino, A; Belmonte, B; Gramignoli, R; et al.
INTERNATIONAL JOURNAL OF CANCER
IF WOS: 5.145 SJR: 2.154 Best Quartile: Q1
Posizione: 1/14